NVST — Envista Holdings Corp
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1757073 ·
Last close
$23.70
Market Cap
$3.80B
52W High
$30.42
52W Low
$18.77
ADV30
3,163,123
Next earnings
2027-02-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 691,500,000 | 400,600,000 | 87,100,000 | 508,300,000 | 5,611,000,000 | 1,158,800,000 | 2,522,400,000 |
| Jun 2026 | 730,500,000 | 407,000,000 | 80,300,000 | 53,700,000 | 5,597,100,000 | 1,125,600,000 | 2,520,800,000 |
| Mar 2026 | 705,500,000 | 390,100,000 | 66,200,000 | 38,700,000 | 5,578,000,000 | 1,082,800,000 | 2,498,500,000 |
| Dec 2025 | 750,600,000 | 410,600,000 | 93,000,000 | 32,900,000 | 5,679,000,000 | 1,211,700,000 | 2,572,700,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$301,800,000
Investing CF
$-111,800,000
Financing CF
$-141,100,000
CapEx
$-59,800,000
Dividends Paid
—
Buybacks
$-137,300,000
EPS Diluted TTM
$3.87
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$160,300,000
Inventory
$285,200,000
Receivables
$448,500,000
ST Investments
—
EBIT TTM
$718,600,000
Pretax Income TTM
$684,400,000
Interest Exp TTM
$34,200,000
Analysts
13
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,878,099,968
EBITDA
$416,200,000
Free Cash Flow
$231,862,496
Enterprise Value
$4,464,582,144
Total Cash
$1,158,800,000
Total Debt
$1,587,500,032
Shares Out
160,344,938
Trailing EPS
$3.85
Book Value
$19.27
ROE
20.5%
ROA
3.4%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,719,500,000 | 235,800,000 | 47,000,000 | 5,679,000,000 | 2,572,700,000 | 3,106,300,000 | 275,700,000 |
| Dec 2024 | 2,510,600,000 | 137,200,000 | -1,118,600,000 | 5,350,500,000 | 2,415,700,000 | 2,934,800,000 | 336,500,000 |
| Dec 2023 | 2,566,500,000 | 314,900,000 | -100,200,000 | 6,605,100,000 | 2,431,200,000 | 4,173,900,000 | 275,700,000 |
| Dec 2022 | 2,569,100,000 | 343,200,000 | 243,100,000 | 6,587,000,000 | 2,380,100,000 | 4,206,900,000 | 182,700,000 |
TTM Snapshot
Revenues TTM
$2,856,500,000
NetIncome TTM
$95,000,000
OpCashFlow TTM
—
Assets (Latest)
$5,597,100,000
Forward EPS
$1.67
Max Pain — expiry 2026-12-18
max pain strike: $25.00 · spot: $23.75 · call oi: 6,657 · put oi: 6,525Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HTFL | Heartflow, Inc. | $4.14B | $47.07 | — |
| ITGR | Integer Holdings Corp | $4.32B | $126.97 | — |
| AXGN | Axogen, Inc. | $3.31B | $55.37 | — |
| PLSE | PULSE BIOSCIENCES, INC. | $3.30B | $44.84 | — |
| ICUI | ICU MEDICAL INC/DE | $4.42B | $176.91 | — |
News headlines (Yahoo Finance, 1h cache)
Here's Why You Should Retain NVST Stock in Your Portfolio for Now
2026-11-13 17:14 · Yahoo
Envista Announces Pricing of $430 Million of Senior Notes
2026-11-10 21:50 · Yahoo
Envista’s Q3 2026 earnings call: our top 5 analyst questions
2026-11-08 22:13 · Yahoo
Envista (NVST) Stock Could Trade Below Fair Value Following A 42% Fall
2026-11-06 04:32 · Yahoo
Envista Q3 Earnings Call Highlights '26 Guidance Raise & China Risks
2026-11-05 18:53 · Yahoo
Earnings Beat Might Change The Case For Envista Stock
2026-11-05 17:15 · Yahoo
Envista (NVST) Q3 2026 Earnings Call Transcript
2026-11-05 16:21 · Yahoo
Envista Holdings Corp Q3 2026 Earnings Call Summary
2026-11-05 13:30 · Yahoo
Envista Holdings (NVST) Could Be 8% Undervalued On Strong Earnings Guidance
2026-11-05 13:17 · Yahoo
What Envista (NVST) Said on Its Q3 Earnings Call
2026-11-05 11:14 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.